tiprankstipranks
Trending News
More News >
Niva Bupa Health Insurance Company Limited (IN:NIVABUPA)
:NIVABUPA
India Market
Advertisement

Niva Bupa Health Insurance Company Limited (NIVABUPA) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

NIVABUPA Analyst Ratings

Moderate Buy
1Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Niva
Bupa Health Insurance Company Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NIVABUPA Stock 12 Month Forecast

Average Price Target

₹92.00
▲(13.15% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Niva Bupa Health Insurance Company Limited in the last 3 months. The average price target is ₹92.00 with a high forecast of ₹92.00 and a low forecast of ₹92.00. The average price target represents a 13.15% change from the last price of ₹81.31.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"71":"₹71","82":"₹82","93":"₹93","76.5":"₹76.5","87.5":"₹87.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":92,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹92.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":92,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹92.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":92,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹92.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[71,76.5,82,87.5,93],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.54,82.3446153846154,83.14923076923077,83.95384615384616,84.75846153846155,85.56307692307692,86.36769230769231,87.1723076923077,87.97692307692309,88.78153846153846,89.58615384615385,90.39076923076924,91.19538461538461,{"y":92,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.54,82.3446153846154,83.14923076923077,83.95384615384616,84.75846153846155,85.56307692307692,86.36769230769231,87.1723076923077,87.97692307692309,88.78153846153846,89.58615384615385,90.39076923076924,91.19538461538461,{"y":92,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.54,82.3446153846154,83.14923076923077,83.95384615384616,84.75846153846155,85.56307692307692,86.36769230769231,87.1723076923077,87.97692307692309,88.78153846153846,89.58615384615385,90.39076923076924,91.19538461538461,{"y":92,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":72.53,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":72.53,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":72.53,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":72.53,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":72.53,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":72.53,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":72.53,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":74.45,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":83.82,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":81.15,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":73.01,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":73.01,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":81.54,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target₹92.00Average Price Target₹92.00Lowest Price Target₹92.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
ICICI Securities Analyst forecast on IN:NIVABUPA
ICICI Securities
ICICI Securities
₹90₹92
Buy
13.15%
Upside
Reiterated
08/11/25
ICICI Securities Sticks to Their Buy Rating for Niva Bupa Health Insurance Company Limited (NIVABUPA)
Morgan Stanley Analyst forecast on IN:NIVABUPA
Morgan Stanley
Morgan Stanley
₹88₹76
Hold
-6.53%
Downside
Reiterated
03/12/25
Niva Bupa Health Insurance (NIVABUPA:IN) PT Lowered to INR76 at Morgan StanleyMorgan Stanley analyst Subramanian Iyer lowered the price target on Niva Bupa Health Insurance (NIVABUPA:IN) to INR76.00 (from INR88.00) while maintaining a Equalweight rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
ICICI Securities Analyst forecast on IN:NIVABUPA
ICICI Securities
ICICI Securities
₹90₹92
Buy
13.15%
Upside
Reiterated
08/11/25
ICICI Securities Sticks to Their Buy Rating for Niva Bupa Health Insurance Company Limited (NIVABUPA)
Morgan Stanley Analyst forecast on IN:NIVABUPA
Morgan Stanley
Morgan Stanley
₹88₹76
Hold
-6.53%
Downside
Reiterated
03/12/25
Niva Bupa Health Insurance (NIVABUPA:IN) PT Lowered to INR76 at Morgan StanleyMorgan Stanley analyst Subramanian Iyer lowered the price target on Niva Bupa Health Insurance (NIVABUPA:IN) to INR76.00 (from INR88.00) while maintaining a Equalweight rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Niva Bupa Health Insurance Company Limited

1 Month
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+3.90%
reiterated a xxx
rating 26 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +3.90% per trade.
3 Months
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+3.90%
reiterated a xxx
rating 26 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +3.90% per trade.
1 Year
Ansuman DebICICI Securities
Success Rate
1/1 ratings generated profit
100%
Average Return
+3.90%
reiterated a buy rating 26 days ago
Copying Ansuman Deb's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +3.90% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+3.90%
reiterated a xxx
rating 26 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +3.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NIVABUPA Analyst Recommendation Trends

Rating
Mar 25
Aug 25
Strong Buy
0
0
Buy
0
1
Hold
1
1
Sell
0
0
Strong Sell
0
0
total
1
2
In the current month, NIVABUPA has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. NIVABUPA average Analyst price target in the past 3 months is 92.00.
Each month's total comprises the sum of three months' worth of ratings.

NIVABUPA Financial Forecast

NIVABUPA Earnings Forecast

Next quarter’s earnings estimate for NIVABUPA is ₹0.04 with a range of ₹0.04 to ₹0.04. The previous quarter’s EPS was -₹0.50. NIVABUPA beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.19% of the time in the same period. In the last calendar year NIVABUPA has Outperformed its overall industry.
Next quarter’s earnings estimate for NIVABUPA is ₹0.04 with a range of ₹0.04 to ₹0.04. The previous quarter’s EPS was -₹0.50. NIVABUPA beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.19% of the time in the same period. In the last calendar year NIVABUPA has Outperformed its overall industry.

NIVABUPA Sales Forecast

Next quarter’s sales forecast for NIVABUPA is ₹19.65B with a range of ₹19.65B to ₹19.65B. The previous quarter’s sales results were ₹11.13B. NIVABUPA beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.32% of the time in the same period. In the last calendar year NIVABUPA has Preformed in-line its overall industry.
Next quarter’s sales forecast for NIVABUPA is ₹19.65B with a range of ₹19.65B to ₹19.65B. The previous quarter’s sales results were ₹11.13B. NIVABUPA beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.32% of the time in the same period. In the last calendar year NIVABUPA has Preformed in-line its overall industry.

NIVABUPA Stock Forecast FAQ

What is IN:NIVABUPA’s average 12-month price target, according to analysts?
Based on analyst ratings, Niva Bupa Health Insurance Company Limited’s 12-month average price target is 92.00.
    What is IN:NIVABUPA’s upside potential, based on the analysts’ average price target?
    Niva Bupa Health Insurance Company Limited has 13.15% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Niva Bupa Health Insurance Company Limited a Buy, Sell or Hold?
          Niva Bupa Health Insurance Company Limited has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Niva Bupa Health Insurance Company Limited’s share price target?
            The average share price target for Niva Bupa Health Insurance Company Limited is 92.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is ₹92.00 ,and the lowest forecast is ₹92.00. The average share price target represents 13.15% Increase from the current price of ₹81.31.
              What do analysts say about Niva Bupa Health Insurance Company Limited?
              Niva Bupa Health Insurance Company Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
                How can I buy shares of Niva Bupa Health Insurance Company Limited?
                To buy shares of IN:NIVABUPA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis